Furthermore, in a mouse AD model with systemic administration of cAC253 results in attenuation of key indices of brain inflammation-activated and reactive microglia (Iba-1, CD68), the inflammasome NLRP3, caspase-1, and pro-inflammatory cytokines, IL-1β and TNFα. The gene discussed is AIF1; the disease is Alzheimer disease.